298 related articles for article (PubMed ID: 24041890)
1. In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
Gregson L; Goodwin J; Johnson A; McEntee L; Moore CB; Richardson M; Hope WW; Howard SJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5778-80. PubMed ID: 24041890
[TBL] [Abstract][Full Text] [Related]
2. Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Buil JB; Brüggemann RJM; Wasmann RE; Zoll J; Meis JF; Melchers WJG; Mouton JW; Verweij PE
J Antimicrob Chemother; 2018 Jan; 73(1):134-142. PubMed ID: 29048485
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Arendrup MC; Jensen RH; Cuenca-Estrella M
Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
5. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
6. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
[TBL] [Abstract][Full Text] [Related]
7. Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
Escribano P; Recio S; Peláez T; Bouza E; Guinea J
Antimicrob Agents Chemother; 2011 May; 55(5):2460-2. PubMed ID: 21321141
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
[TBL] [Abstract][Full Text] [Related]
9.
Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
[TBL] [Abstract][Full Text] [Related]
10. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
11. Azole preexposure affects the Aspergillus fumigatus population in patients.
Alanio A; Cabaret O; Sitterlé E; Costa JM; Brisse S; Cordonnier C; Bretagne S
Antimicrob Agents Chemother; 2012 Sep; 56(9):4948-50. PubMed ID: 22710122
[TBL] [Abstract][Full Text] [Related]
12. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Rodriguez-Tudela JL; Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Monzon A; Cuenca-Estrella M
Antimicrob Agents Chemother; 2008 Jul; 52(7):2468-72. PubMed ID: 18474574
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Tashiro M; Izumikawa K; Minematsu A; Hirano K; Iwanaga N; Ide S; Mihara T; Hosogaya N; Takazono T; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yamamoto Y; Yanagihara K; Yasuoka A; Tashiro T; Kohno S
Antimicrob Agents Chemother; 2012 Jan; 56(1):584-7. PubMed ID: 22024829
[TBL] [Abstract][Full Text] [Related]
15. Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved.
Simon L; Déméautis T; Dupont D; Kramer R; Garnier H; Durieu I; Sénéchal A; Reix P; Couraud S; Devouassoux G; Lina B; Rabodonirina M; Wallon M; Dannaoui E; Persat F; Menotti J
Int J Antimicrob Agents; 2021 Dec; 58(6):106447. PubMed ID: 34619334
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
Astvad KMT; Hare RK; Arendrup MC
Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
[TBL] [Abstract][Full Text] [Related]
17. Azole resistance in canine and feline isolates of Aspergillus fumigatus.
Talbot JJ; Kidd SE; Martin P; Beatty JA; Barrs VR
Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():37-41. PubMed ID: 26387063
[TBL] [Abstract][Full Text] [Related]
18. Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Beernaert LA; Pasmans F; Van Waeyenberghe L; Dorrestein GM; Verstappen F; Vercammen F; Haesebrouck F; Martel A
Antimicrob Agents Chemother; 2009 May; 53(5):2199-201. PubMed ID: 19258265
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
Meletiadis J; Mavridou E; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2012 May; 56(5):2524-9. PubMed ID: 22330922
[TBL] [Abstract][Full Text] [Related]
20. Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
Lazzarini C; Esposto MC; Prigitano A; Cogliati M; De Lorenzis G; Tortorano AM
Antimicrob Agents Chemother; 2016 Jan; 60(1):682-5. PubMed ID: 26552980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
